Impact of socioeconomic wealth on chronic limb-threatening ischemia revascularization outcomes among Medicare patients from 2016 to 2023.

Impact of socioeconomic wealth on chronic limb-threatening ischemia revascularization outcomes among Medicare patients from 2016 to 2023.

Publication date: Jan 01, 2026

Prompt revascularization is crucial for managing for chronic limb-threatening ischemia (CLTI), but disparities in socioeconomic status (SES) and health care access affect outcomes. The COVID-19 pandemic exacerbated these inequities, yet their impact on CLTI outcomes remains underexplored. This study evaluated the association between regional SES, measured by the Distressed Communities Index (DCI), and outcomes-including mortality, major amputation, and repeat interventions-before, during, and after the COVID-19 pandemic in Medicare beneficiaries undergoing CLTI revascularization. From 2016 to 2023, Medicare beneficiaries undergoing CLTI endovascular revascularization were stratified by SES using the DCI (distressed, ≥80th percentile). The study periods were prepandemic (January 1, 2016, to March 31, 2020), pandemic (March 31, 2020, to December 31, 2021), and late pandemic (December 31, 2021, to December 31, 2023). Metrics were evaluated before and after revascularization. End points were analyzed using Kaplan-Meier and Cox models adjusted for demographics and clinical factors. Among 333,173 beneficiaries, 66,757 (20. 0%) lived in distressed communities, facing higher risks of major amputation and mortality (hazard ratio [HR] 1. 04; 95% confidence interval [CI], 1. 03-1. 05; P

Concepts Keywords
Medicare Aged
Pandemic Aged, 80 and over
Revascularization Amputation, Surgical
Socioeconomic Chronic Disease
Chronic Limb-Threatening Ischemia
CLTI
COVID-19
Endovascular Procedures
Female
Healthcare Disparities
Humans
Ischemia
Limb Salvage
Limb salvage
Male
Medicare
Medicare
Peripheral Arterial Disease
Peripheral arterial disease
Retrospective Studies
Risk Factors
SARS-CoV-2
Social Class
Socioeconomic Factors
Socioeconomic status
Time Factors
Treatment Outcome
United States

Semantics

Type Source Name
disease MESH chronic limb-threatening ischemia
disease MESH COVID-19 pandemic
drug DRUGBANK Dichloroisoproterenol
disease MESH emergency
disease MESH Chronic Disease
disease MESH Ischemia
disease MESH Peripheral Arterial Disease

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *